Skip to main content
BGI Genomics Co., Ltd. logo

BGI Genomics Co., Ltd. — Investor Relations & Filings

Ticker · 300676 ISIN · CNE100003449 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 1,656 across all filing types
Latest filing 2020-04-24 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300676

About BGI Genomics Co., Ltd.

https://www.bgi.com

BGI Genomics Co., Ltd. is a leading provider of integrated solutions for precision medicine, specializing in genomic sequencing and proteomic services. The company offers a comprehensive portfolio of clinical diagnostics and research services across various fields, including reproductive health, oncology, and infectious diseases. Key products include non-invasive prenatal testing, hereditary cancer screening, and pathogen identification tools. Leveraging proprietary DNBseq sequencing technology, BGI Genomics provides high-throughput, cost-effective genomic data analysis to healthcare providers, research institutions, and pharmaceutical companies worldwide. The organization focuses on advancing personalized medicine through large-scale genomic research and the development of innovative diagnostic applications, aiming to improve health outcomes by making advanced genetic insights accessible to a global population.

Recent filings

Filing Released Lang Actions
第二届董事会第十九次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 19th meeting of the second board of directors of Shenzhen BGI Genomics Co., Ltd. It includes approvals of the 2019 Annual Report and its summary, the 2020 Q1 report, the 2019 board work report, the 2019 general manager work report, financial budget and profit distribution plans, appointment of auditors, internal control evaluation, social responsibility report, employee stock ownership plans, share repurchase plans, and other governance matters. The document references the 2019 Annual Report and 2020 Q1 report as being published on the official disclosure website but does not contain the full financial statements or detailed financial data itself. It is a board meeting resolution announcement that includes approvals of various reports and plans, many of which will be submitted to the shareholders' meeting for approval. The document is lengthy (over 12,000 characters) and contains substantive content about board decisions, but it is not the actual annual report or quarterly report itself. It is not a simple announcement of report publication but a detailed board meeting resolution document. This fits best under the category of Board/Management Information (MANG), which covers announcements of board decisions and management matters. Therefore, the filing type is MANG with high confidence.
2020-04-24 Chinese
关于2019年年度报告及2020年第一季度报告披露提示性公告
Report Publication Announcement Classification · 100% confidence The document is a short announcement (498 characters) stating that the company has disclosed its 2019 Annual Report and 2020 First Quarter Report on a regulatory website. It does not contain the actual reports or financial data but informs investors where to find them. According to the 'MENU VS MEAL' rule, this is a Report Publication Announcement (RPA), not the reports themselves.
2020-04-24 Chinese
2019年年度审计报告
Audit Report / Information Classification · 95% confidence The document is titled as "已审财务报表" which translates to "Audited Financial Statements" for the year 2019. It includes an audit report by Ernst & Young (安永华明), detailed financial statements such as consolidated balance sheets, income statements, cash flow statements, and notes to the financial statements. The audit report contains the auditor's opinion, basis for opinion, key audit matters, responsibilities of management and auditors, and signatures of certified public accountants. The document length is substantial (15,000 characters) and contains the full audited financial statements, not just an announcement or certification. This matches the definition of an Audit Report / Information (AR) filing, which includes standalone audit reports and applied accounting principles, excluding full annual reports. Although it contains financial statements, the presence of a detailed audit report and the title "已审财务报表" indicates it is primarily an audit report document rather than a full annual report (10-K). Therefore, the correct classification is AR with high confidence. FY 2019
2020-04-24 Chinese
中信证券股份有限公司关于《深圳华大基因股份有限公司2019年度内部控制评价报告》的核查意见
Audit Report / Information Classification · 95% confidence The document is titled as an opinion from CITIC Securities Co., Ltd. regarding the "2019 Annual Internal Control Evaluation Report" of Shenzhen BGI Genomics Co., Ltd. It discusses the scope, basis, and conclusions of the internal control evaluation, including references to regulatory requirements and a prior regulatory corrective decision. The document is a verification or review opinion on the internal control evaluation report rather than the report itself. It does not contain full financial statements or comprehensive financial data but rather an audit or review opinion on internal controls. This fits the category of an Audit Report / Information (AR), which includes standalone audit reports and internal control evaluations. The document length is 2439 characters, which is relatively short but contains substantive content beyond a mere announcement. Therefore, the classification is AR with high confidence. FY 2019
2020-04-24 Chinese
2019年度募集资金存放与实际使用情况专项鉴证报告（2019年12月31日）
Audit Report / Information Classification · 95% confidence The document is titled as a "专项鉴证报告" (Special Verification Report) regarding the "募集资金存放与实际使用情况" (funds raised storage and actual usage) for the year 2019 by Shenzhen BGI Genomics Co., Ltd. It includes detailed audited information about the raised funds, their storage, management, and actual usage, with references to regulatory guidelines from the China Securities Regulatory Commission and Shenzhen Stock Exchange. The document is prepared by an accounting firm (Ernst & Young Hua Ming) providing an assurance opinion on the special report. This type of document is a standalone audit or assurance report focused on the use of raised capital, not a full annual report or interim report. It is not a mere announcement or certification but contains substantive audited information. Therefore, it fits the category of an Audit Report / Information (AR). FY 2019
2020-04-24 Chinese
2019年度独立董事述职报告（蒋昌建）
Board/Management Information Classification · 95% confidence The document is titled '2019年度独立董事述职报告' which translates to '2019 Annual Independent Director's Work Report'. It details the independent director's activities, attendance at board meetings, opinions on various company matters, committee work, investigations, investor protection efforts, and training during the 2019 fiscal year. The content focuses on the independent director's duties and oversight rather than financial results or audit opinions. It is a report on board/management activities and governance oversight rather than a financial report or audit report. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is 5848 characters, which is sufficient for a detailed report rather than a brief announcement. There is no indication that this is an announcement of a report or a certification letter, so it is not RPA or RNS. Hence, the classification is MANG with high confidence.
2020-04-24 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.